Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibody Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +12.00p +7.84% 165.00p 160.00p 170.00p 170.00p 150.00p 153.00p 52,668 16:20:32
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 36.45

Fusion Antibody Share Discussion Threads

Showing 51 to 71 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
12/1/2018
14:26
MM could drop this to £1
fhasson
12/1/2018
09:47
Price now just above prior common gap. Would prefer to see the gap filled. potential turn date 22 January.
bamboo2
07/1/2018
21:04
luci, I would also be interested to see your evidence.
bamboo2
07/1/2018
20:50
Is there going to be a dilution of share price? Where are you getting this information from? Would appreciate your input.Thanks
fhasson
07/1/2018
20:43
What's going to 50p?
fhasson
07/1/2018
18:39
going to 50p secondary placing coming
lucicavi
07/1/2018
18:18
http://www.cellandgenetherapyworld.com/resources/blog/the-viral-vector-challenge-capacity-or-quality
fhasson
05/1/2018
14:45
I'm in at 166p .These should multibag in 1-3 years IMO . DYOR
fhasson
05/1/2018
11:12
OXB hitting off ... excellent potential
fhasson
05/1/2018
10:05
Thanks Bamboo , just annoyed I missed IPO price and trying to get good entry point. Strongly believe on my research this will do well in time .
fhasson
05/1/2018
08:35
fhasson, there's very little to go on, on the daily chart that I use, due to the newness of the ipo. The gap however is of a type that I would expect to be filled relatively soon.
bamboo2
04/1/2018
15:29
Aim for 125 then?
fhasson
04/1/2018
13:06
Chart shows a small area gap 18-19/12/2017 125-125.5 This could be a good entry point.
bamboo2
04/1/2018
01:09
Keen to add these to my portfolio. Aiming for further retrace though! Once Car-T hits off for immuno- oncology blockbuster cures there will be more potential growth for companies like FAB. Already in the bag for monoclonal antibody treatments on a global scale which is ever- increasing but the future is MAB and Car-T for chronic disease management and cancer treatment/ cure.Should be a multi- bagger . For LTH .
fhasson
27/12/2017
15:59
cannot buy in any large numbers
falia
27/12/2017
15:53
Beware falia pump and dump
dave4545
27/12/2017
15:52
cannot buy £2.50+ tomorrow
falia
27/12/2017
11:24
rocket time
falia
27/12/2017
10:52
The rise continues unabated though of course the stock is quite illiquid so this can work both ways..
gersemi
23/12/2017
16:04
Hoping for some retrace then I am in for 3- 5 years minimum. Holding heavy with OXB which I think will complement FAB when they start to hit off. Yuletide greetings to our homegrown unicorn potential scientists at Queens
fhasson
20/12/2017
20:52
Interesting you should mention Horizon gersemi. Horizon were one of the peer group comparitors used in Allenby's Pre-IPO research note (see below)
timbo003
Chat Pages: 3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180116 19:25:27